Results 201 to 210 of about 25,411 (262)

Discontinuation and reinitiation of mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction. [PDF]

Eur J Heart Fail
Landucci L, Faxén UL, Benson L, Dahlström U, Carrero JJ, Savarese G, Lund LH.   +6 more
europepmc   +1 more source

Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death across cardio-kidney-metabolic diseases: A meta-analysis of randomized clinical trials. [PDF]

Eur J Heart Fail
Marques P, Zannad F, Ferreira JP.
europepmc   +1 more source

Aldosterone's impact on kidney health: exploring the benefits of mineralocorticoid receptor antagonists for renal protection. [PDF]

Am J Transl Res
Liu Z, Xie B, Pang S, Xie Y, Jili M, Mo Z, Li W, Yang R.   +7 more
europepmc   +1 more source

Treatment Patterns, Adverse Events, and Clinical Outcomes with Steroidal Mineralocorticoid Receptor Antagonists: A Retrospective Analysis of Administrative Claims Data (RELICS). [PDF]

Pragmat Obs Res
Richard EL, Desai NR, Willey VJ, Gay A, Scott C, Folkerts K, Pessina E, Singh R, Teng CC, Oberprieler NG.   +9 more
europepmc   +1 more source

Efficacy of Mineralocorticoid Receptor Antagonists on Kidney and Cardiovascular Outcomes in Patients With Chronic Kidney Disease: An Umbrella Review. [PDF]

Kidney Med
Amornritvanich P, Anothaisintawee T, Attia J, McKay GJ, Thakkinstian A.   +4 more
europepmc   +1 more source

Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review. [PDF]

Biomedicines
Miyasako K, Maeoka Y, Masaki T.
europepmc   +1 more source

Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models. [PDF]

Int J Mol Sci
Varda L, Ekart R, Lainscak M, Maver U, Bevc S.   +4 more
europepmc   +1 more source

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease: Clinical Evidence and Potential Adverse Events. [PDF]

Clin Diabetes
Upadhyay A, Haider L.
europepmc   +1 more source

Effectiveness and safety of mineralocorticoid receptor antagonists in heart failure patients with and without diabetes: a systematic review and meta-analysis. [PDF]

Egypt Heart J
Adji AS, Widjaja JS, de Liyis BG.
europepmc   +1 more source

Targeting Diabetic Atherosclerosis: The Role of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Vascular Protection and Disease Modulation. [PDF]

Biomedicines
Rroji M, Spahia N, Figurek A, Spasovski G.   +3 more
europepmc   +1 more source